0000950170-24-071308.txt : 20240610 0000950170-24-071308.hdr.sgml : 20240610 20240610161508 ACCESSION NUMBER: 0000950170-24-071308 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240607 FILED AS OF DATE: 20240610 DATE AS OF CHANGE: 20240610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wooster Richard CENTRAL INDEX KEY: 0001774790 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40287 FILM NUMBER: 241032872 MAIL ADDRESS: STREET 1: C/O TRANSLATE BIO, INC. STREET 2: 29 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ikena Oncology, Inc. CENTRAL INDEX KEY: 0001835579 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVE. CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 857-343-8292 MAIL ADDRESS: STREET 1: 50 NORTHERN AVE. CITY: BOSTON STATE: MA ZIP: 02210 4 1 ownership.xml 4 X0508 4 2024-06-07 0001835579 Ikena Oncology, Inc. IKNA 0001774790 Wooster Richard C/O IKENA ONCOLOGY, INC. 645 SUMMER STREET, SUITE 101 BOSTON MA 02210 true false false false false Stock Option (Right to Buy) 1.75 2024-06-07 4 A false 17520 0.00 A 2034-06-06 Common Stock 17520 17520 D This option shall vest in full upon the earlier of (i) June 7, 2025 or (ii) the date of the next annual meeting; provided, however, that all vesting shall cease if the director resigns from the Board or otherwise ceases to serve as a director. /s/ Mark Manfredi, as Attorney-in-Fact for Richard Wooster 2024-06-10